Rod Taylor

💥 SUPER MSL: The Quest to Become the TOP MSL on Your Team💥 Don't miss this weeks MSL Talk podcast with Daniel Snyder, Ph.D., Senior Medical Affairs & HEOR Leader who discusses the differentiators for MSLs that will make you stand out and become the top MSL on your team. Learn more about….   👉 The qualities and differentiators of a “Super MSL” 👉 The skills and attributes that make MSLs stand out relative to their peers 👉 What common mistakes do MSLs need to avoid to 👉 What MSL Team leader should do to encourage and entice ideal MSL skills The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.     MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.   #msl #medicalaffairs #medicalscienceliaison #MSLtalk #careers  

32

3 Comments

💥 SUPER MSL: The Quest to Become the TOP MSL on Your Team💥 Don't miss this weeks MSL Talk podcast with Daniel Snyder, Ph.D., Senior Medical Affairs & HEOR Leader who discusses the differentiators for MSLs that will make you stand out and become the top MSL on your team. Learn more about…. 👉 The qualities and differentiators of a “Super MSL” 👉 The skills and attributes that make MSLs stand out relative to their peers 👉 What common mistakes do MSLs need to avoid to 👉 What MSL Team leader should do to encourage and entice ideal MSL skills The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel. MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions. #msl #medicalaffairs #medicalscienceliaison #MSLtalk #careers

27

1 Comment

What an interesting read on the shift from traditional patient recruitment methods in rare disease! Learn more about how to optimize patient-driven site engagement in my team member’s blog: https://bit.ly/4eHoBn4

3

I'll leave the legal issues to you - what I cannot ascertain is has anyone commented on, if the IRA plan expands as people have said it will, then how will new drug discovery be funded? It's an incredibly time consuming and expensive process. To expect companies to do this for free isn't reasonable. Once the trials are in humans, the investigators and institutions need to be funded. In some cases the administrative costs are high as well: patient travel, patient hospitalization and other family domiciling, new machinery, staff to administer trial drug, monitor patients, etc. Then of course there is the ROW benefits of the American system paying for drug. Innovation year over year is what is saving lives. I'm not sure how the whole process works if we stunt it on a larger scale.

1

Like this note from Vas.

3

In #NeurodegenerativeDisease news, specifically on an experimental treatment for #ALS, with this new #strategic partnership is penned between Dewpoint Therapeutics and Mitsubishi Tanabe Pharma America. ⚛️ The asset is the former's drug, designed "to address the accumulation of a protein into toxic structures that lead to neuronal dysfunction in people with ALS." 🤝 The alliance would grant MTP exclusive rights to license, upon achieving certain developmental milestones. ⚕️ This would add to MTP's existing US-marketed ALS treatment, #Radicava https://lnkd.in/evayrVv4' #Dewpoint #Mitsubishi #Pharma #Biopharma #Healthcare

6

#ICYMI: Watch our full webinar recording to explore how medical affairs is uniquely positioned to infuse drug development with the voice of the patient and bring scientific information with patient communities that benefit all: https://ow.ly/8BPp30sEVMZ #SyneosHealth

7

Hot off the press! CMS has recently released a video that talks about The Medicare Prescription Payment Plan and how seniors can select smoothing. This has been a concern for many pharma programs - here is the link below to share with all your colleagues to share with patients. #CMS #Medicareprescriptionpaymentplan #Medicare #Smoothing

1

5 Comments

Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of Astagraf XL 0.5 mg Because Bottles Shipped to U.S. May Contain Empty Capsules Audience: Healthcare Provider, Pharmacy, Consumer NORTHBROOK, IL, Dec, 2024 – Astellas Pharma US, Inc. is voluntarily recalling one lot of Prograf® 0.5mg (tacrolimus) and one lot of Astagraf XL® 0.5mg (tacrolimus extended-release) capsules to the consumer level. These products are being recalled because bottles may contain empty capsules Lonza Capsules & Health Ingredients PillSorted Retail Pharmacy Magazine Rexall Pharmacy Group ULC KSAU-HS College of Pharmacy  Dubai Pharmacy College for Girls Pharmacy Business Pharmacy Practice News EPUT Pharmacy Amazon Pharmacy Pharmacy Purchasing & Products Pharmacy Jobs Université du 8 mai 1945 Guelma

5

Looking forward to attending #ASH2024 this year. Let's connect and I can share with you how TD2 can support your next trial. 🔗https://hubs.li/Q02YXgqv0 #HematologyOncology #ClinicalTrials #OncologyCRO #BloodCancerResearch #DrugDevelopment #PrecisionOncology #ClinicalTrialSolutions

1

💡 Unlock Your Pharmacy's Value! Dr. Lisa Faast dives into pharmacy valuation, covering key factors like contracts, licenses, staff stability, and efficient operations. Learn how joining Care can even double your value! Don’t miss out—watch the full video and start boosting your pharmacy’s worth today! https://lnkd.in/ejjdZb-6 #diversifyrx #independentpharmacy #localpharmacy #communitypharmacy #smallpharmacyowner #smallbusinessowner #PharmacyWorthPart2 #PharmacyValuation #PharmacyBusiness #PharmacyTips #PharmacyProfitSummit #LisaFaast #PharmacyOwners

3

2 Comments

Thoughts on this? >> The Biden administration wants Medicare and Medicaid to cover GLP-1s. Will the Trump White House allow it? >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #healthcare #pharma #pharmaceutical #biotech

1

As payers seek to take back control of their pharmacy and medical spend, Site of Care (SOC) optimization is an opportunity to capture savings. Check out AscellaHealth's recent Payer Spotlight to learn more: https://lnkd.in/e6XPzvhi #payersolutions #managingcosts #specialtytherapies #specialtypharmacy #HealthcarePayers #healthplans

11

📣 Ever wondered how Medicare for All could transform healthcare in the U.S.? 🤔 Imagine a system where health insurers, PBMs, and pharmaceutical companies work together seamlessly! Here's a thought: - Implement a Medicare Advantage plan. - The plan would be administered by a company on behalf of the government. - Ensure comprehensive coverage with a capped cost. - Physicians would benefit from reduced administrative burdens. This approach could streamline processes, cut costs, and improve access to health services for everyone. 🌟 What are your thoughts on making healthcare more effective and efficient? Share your ideas in the comments! #MedicareForAll #HealthcareReform #MedicareAdvantage #HealthInsurance #PublicHealth #CostEfficiency

16

3 Comments